{
  "ticker": "ELS",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02970962",
  "id": "02970962",
  "pages": 10,
  "price_sensitive": true,
  "date": "20250721",
  "time": "0920",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250721/pdf/06lzdrwhwqtk5h.pdf",
  "summary": "Here\u2019s the material information extracted and formatted as per your guidelines:\n\n**Quarterly Report (Appendix 4C) & Business Update**  \n- **Revenue**:  \n  - Q2 2025: **~US$3.8M (~A$5.8M)** (270% QoQ growth).  \n  - H1 2025: **~US$4.8M (~A$7.4M)** (340% YoY growth).  \n- **Order Book**: **~US$11.45M (~A$17.5M)** remaining for CY2025 delivery.  \n- **Cash Balance**: **~US$7.5M (~A$11.5M)** as of 30 June 2025 (up from ~US$883K in Q1).  \n- **Key Contracts**:  \n  - Three contracts totaling **~US$14.7M (~A$22.8M)** secured in Q2 (40% upfront payment, 60% pre-shipment).  \n- **Profitability Target**: Expected in H2 2025 (first time since IPO).  \n- **Pipeline**: **~US$151M** realisable opportunities in defence/commercial sectors.  \n- **Production Capacity**: Expanding to **~US$150M/year** (new EU manufacturer in H2, zero capex).  \n- **Debt Facility**: **US$629K** unsecured loan (9% p.a., maturing Sept 2026).  \n\n**Operational Highlights**:  \n- Recurring revenue growth (software/licenses).  \n- Supply chain resilience: US$70M/year current capacity, scalable to demand.  \n- Selected for Northrop Grumman\u2013FedTech Accelerator (U.S. DoD access).  \n\n**No material capital raising, trading halt, or other structural changes identified.**  \n\n*Note: Omitted non-material operational/descriptive details.*",
  "usage": {
    "prompt_tokens": 5623,
    "completion_tokens": 401,
    "total_tokens": 6024,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-20T23:33:44.754121"
}